
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Albinism historical perspective
Introduction
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Overview
Overview
Albinism was first discovered in 1908 by a British physician named Sir Archibald Edward Garrod. At first, it was believed that albinism is caused by a lack of melanocytes. In late 1950, it was proved that albinism is caused by tyrosine kinase inactivity.
Historical Perspective
Historical Perspective
Discovery
- The discovery of albinism occured as the following: [1] [2] [3]
- Albinism, from the Latin Albu, means white
- In 1908, a British physician named Sir Archibald Edward Garrod discovered Albinism
- Sir Archibald Edward Garrod stated that albinism is caused by failure of an intercellular activity
- In late 1950, it was proved that albinism is caused by tyrosine kinase inactivity, not due to lack of melanocytes
- Between 1920-1935, British physiologist H.S.Raper did studies on melanogenesis
- In 1966, Snowflack was the first case of albino gorilla which was discovered
References
References
- ↑ Oetting WS, Fryer JP, Shriram S, King RA (2003). “Oculocutaneous albinism type 1: the last 100 years”. Pigment Cell Res. 16 (3): 307–11. doi:10.1034/j.1600-0749.2003.00045.x. PMID 12753405.
- ↑ MartÃnez-Arias R, Comas D, Andrés A, Abelló MT, Domingo-Roura X, Bertranpetit J (2000). “The tyrosinase gene in gorillas and the albinism of ‘Snowflake‘“. Pigment Cell Res. 13 (6): 467–70. doi:10.1034/j.1600-0749.2000.130609.x. PMID 11153699.
- ↑ Oetting WS (2000). “The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation”. Pigment Cell Res. 13 (5): 320–5. doi:10.1034/j.1600-0749.2000.130503.x. PMID 11041207.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
